IMB-102

N/A

Report date: 2024/03/08 14:48:40

Base Information

Drug NameIMB-102
Drug Alias NameIMB-102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTumor necrosis factor ligand superfamily member 4 modulators
TargetsTumor necrosis factor ligand superfamily member 4
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIMBiologics Corp
China Registration ClassN/A

Develop Information

Active CompaniesHuadong Medicine Co LtdNavigator Medicines IncIMBiologics Corp +[4] 
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A